Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF ) Freely available
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (34)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Marozzi, A.
Right arrow Articles by Ginelli, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Marozzi, A.
Right arrow Articles by Ginelli, E.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Human Reproduction, Vol. 17, No. 7, 1741-1745, July 2002
© 2002 European Society of Human Reproduction and Embryology

Mutation analysis of the inhibin alpha gene in a cohort of Italian women affected by ovarian failure

A. Marozzi1,5, C. Porta1, W. Vegetti2, P.G. Crosignani2, M.G. Tibiletti3, L. Dalprà4 and E. Ginelli1

1 Department of Biology and Genetics, Medical Faculty, University of Milan, Via Viotti 3/5, 20133 Milan, 2 First Department of Obstetrics and Gynaecology, University of Milan, 3 Department of Clinical and Biological Sciences, Ospedale di Circolo, Varese and 4 Department of Experimental and Environmental Medicine and Medical Biotechnology, University of Milan–Bicocca, Monza, Italy

BACKGROUND: Premature ovarian failure (POF) is a secondary hypergonadotrophic amenorrhoea affecting 1–3% of females, whose aetiology is almost unknown. However, inhibin alpha gene (INH{alpha}) has recently been indicated as candidate in POF pathogenesis. METHODS: We analysed patients affected by POF (n = 157) for the missense mutation (769G->A transition) in the exon 2 of the INH{alpha} gene. The same analysis was carried out on early menopause (EM) (n = 36) and primary amenorrhoea (n = 12) patients. RESULTS: The incidence of the mutation was significantly more frequent within both POF (7/157, 4.5%) (Fisher's exact test, P = 0.030) and primary amenorrhoea (3/12, 25%) (Fisher's exact test, P < 0.001) patients, compared with the control population of women (0/100), who experienced physiological menopause. No mutation was found in EM patients. Furthermore, the likelihood of finding the mutation was statistically significant in familial (5/65; 7.7%) (Fisher's exact test, P < 0.01) but not in sporadic (2/92; 2.2%) (Fisher's exact test, P = not significant) POF, compared with the control group. The analysis of pedigrees showing the inheritance of the 769G->A mutation and POF strengthens the concept of the disease heterogeneity, since the POF phenotype was not always associated with the mutation. Moreover, a higher prevalence of the C allele of a single nucleotide polymorphism (129C->T), located in the 5'-UTR of the INH{alpha} gene, was observed in POF patients (80.3%) than in the control group (66.7%) (Fisher's exact test, P = 0.014). CONCLUSION: These data strengthen the concept of the INH{alpha} gene as a candidate for ovarian failure.

Key words: inhibin/mutation/ovarian failure/premature ovarian failure/sterility

5 To whom correspondence should be addressed at: Department of Biology and Genetics for Medical Sciences, University of Milan, Via Viotti 3/5, 20133 Milan, Italy. E-mail: anna.marozzi{at}unimi.it


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Hum ReprodHome page
T. Corre, J. Schuettler, S. Bione, A. Marozzi, L. Persani, R. Rossetti, F. Torricelli, I. Giotti, P. Vogt, D. Toniolo, et al.
A large-scale association study to assess the impact of known variants of the human INHA gene on premature ovarian failure
Hum. Reprod., April 10, 2009; (2009) dep090v1.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
M. P. Purdue, B. I. Graubard, S. J. Chanock, M. V. Rubertone, R. L. Erickson, and K. A. McGlynn
Genetic Variation in the Inhibin Pathway and Risk of Testicular Germ Cell Tumors
Cancer Res., April 15, 2008; 68(8): 3043 - 3048.
[Abstract] [Full Text] [PDF]


Home page
Hum Reprod UpdateHome page
The ESHRE Capri Workshop Group
Genetic aspects of female reproduction
Hum. Reprod. Update, April 2, 2008; (2008) dmn009v1.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
A. Tsigkou, S. Marzotti, L. Borges, A. Brozzetti, F. Reis, P. Candeloro, M. Luisa Bacosi, V. Bini, F. Petraglia, and A. Falorni
High Serum Inhibin Concentration Discriminates Autoimmune Oophoritis from Other Forms of Primary Ovarian Insufficiency
J. Clin. Endocrinol. Metab., April 1, 2008; 93(4): 1263 - 1269.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
A. L. Chand, G. T. Ooi, C. A. Harrison, A. N. Shelling, and D. M. Robertson
Functional analysis of the human inhibin {alpha} subunit variant A257T and its potential role in premature ovarian failure
Hum. Reprod., December 1, 2007; 22(12): 3241 - 3248.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
H. Dixit, K.L. Rao, V.V. Padmalatha, M. Kanakavalli, M. Deenadayal, N. Gupta, B.N. Chakrabarty, and L. Singh
Mutational analysis of the betaglycan gene-coding region in susceptibility for ovarian failure
Hum. Reprod., August 1, 2006; 21(8): 2041 - 2046.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
H. Dixit, K.L. Rao, V. Padmalatha, M. Kanakavalli, M. Deenadayal, N. Gupta, B.N. Chakravarty, and L. Singh
Expansion of the germline analysis for the INHA gene in Indian women with ovarian failure
Hum. Reprod., June 1, 2006; 21(6): 1643 - 1644.
[Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
E. Di Pasquale, R. Rossetti, A. Marozzi, B. Bodega, S. Borgato, L. Cavallo, S. Einaudi, G. Radetti, G. Russo, M. Sacco, et al.
Identification of New Variants of Human BMP15 Gene in a Large Cohort of Women with Premature Ovarian Failure
J. Clin. Endocrinol. Metab., May 1, 2006; 91(5): 1976 - 1979.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
V. Sundblad, V. A. Chiauzzi, L. Andreone, S. Campo, E. H. Charreau, and L. Dain
Controversial role of inhibin {alpha}-subunit gene in the aetiology of premature ovarian failure
Hum. Reprod., May 1, 2006; 21(5): 1154 - 1160.
[Abstract] [Full Text] [PDF]


Home page
Mol Hum ReprodHome page
S. E. Harris, A. L. Chand, I. M. Winship, K. Gersak, Y. Nishi, T. Yanase, H. Nawata, and A. N. Shelling
INHA promoter polymorphisms are associated with premature ovarian failure
Mol. Hum. Reprod., November 1, 2005; 11(11): 779 - 784.
[Abstract] [Full Text] [PDF]


Home page
Hum Reprod UpdateHome page
H. S. Kok, K. M. van Asselt, Y. T. van der Schouw, P. H.M. Peeters, and C. Wijmenga
Genetic studies to identify genes underlying menopausal age
Hum. Reprod. Update, September 1, 2005; 11(5): 483 - 493.
[Abstract] [Full Text] [PDF]


Home page
Hum Reprod UpdateHome page
D. Goswami and G. S. Conway
Premature ovarian failure
Hum. Reprod. Update, July 1, 2005; 11(4): 391 - 410.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
S. Bione, F. Rizzolio, C. Sala, R. Ricotti, M. Goegan, M.C. Manzini, R. Battaglia, A. Marozzi, W. Vegetti, L. Dalpra, et al.
Mutation analysis of two candidate genes for premature ovarian failure, DACH2 and POF1B
Hum. Reprod., December 1, 2004; 19(12): 2759 - 2766.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
H. Dixit, M. Deendayal, and L. Singh
Mutational analysis of the mature peptide region of inhibin genes in Indian women with ovarian failure
Hum. Reprod., August 1, 2004; 19(8): 1760 - 1764.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.